Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51K Buy
236
+47
+25% +$8.99K 0.03% 305
2026
Q1
$34.6K Buy
189
+44
+30% +$8.11K 0.03% 353
2025
Q4
$25.5K Buy
145
+117
+418% +$19.1K 0.02% 450
2025
Q3
$3.92K Buy
28
+25
+833% +$3.38K ﹤0.01% 967
2025
Q2
$377 Hold
3
﹤0.01% 1375
2025
Q1
$411 Sell
3
-6
-67% -$858 ﹤0.01% 1369
2024
Q4
$1.38K Buy
+9
New +$1.52K ﹤0.01% 1174

Other funds holding BIIB

WPG Advisers's BIIB Position: Q2 2026 in Review

WPG Advisers increased its Biogen (BIIB) stake by 25% in Q2 2026, buying an estimated $8.99K and bringing the position to 236 shares worth $51K. The position accounts for 0.03% of the portfolio, ranked #305.

WPG Advisers first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • WPG Advisers held 236 shares of Biogen worth $51K as of Q2 2026.
  • WPG Advisers bought 47 Biogen shares in Q2 2026, an estimated $8.99K.
  • Biogen made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #305 holding.
  • WPG Advisers first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.